We are live on ! Find out more
OQS

Occudo Quantitative Strategies Portfolio holdings

AUM $1.84B
1-Year Est. Return 22.15%
This Fund
S&P 500
This Quarter Est. Return
+9.17%
1 Year Est. Return
+22.15%
3 Year Est. Return
+67.4%
5 Year Est. Return
+61.87%
10 Year Est. Return
AUM
$859M
AUM Growth
-$429M
Cap. Flow
-$442M
Cap. Flow %
-51.43%
Top 10 Hldgs %
4.21%
Holding
1,520
New
386
Increased
181
Reduced
340
Closed
602

Top Buys

Rank Stock Value
1
GOSS icon
Gossamer Bio
GOSS
+$5.95M
2
MRVL icon
Marvell Technology
MRVL
+$4M
3
AAPL icon
Apple
AAPL
+$3.97M
4
DIS icon
Walt Disney
DIS
+$3.95M
5
ROL icon
Rollins
ROL
+$3.82M

Top Sells

Rank Stock Value
1
DDOG icon
Datadog
DDOG
+$7.11M
2
ICE icon
Intercontinental Exchange
ICE
+$6.91M
3
XRAY icon
Dentsply Sirona
XRAY
+$6.81M
4
CSCO icon
Cisco
CSCO
+$6.77M
5
QRVO icon
Qorvo
QRVO
+$6.72M

Sector Composition

Rank Sector Weight
1 Technology 21.95%
2 Consumer Discretionary 16.59%
3 Industrials 13.62%
4 Financials 13.07%
5 Healthcare 7.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ADSK icon
926
Autodesk
ADSK
$49.6B
-9,671
Closed -$1.81M
AEE icon
927
Ameren
AEE
$30.3B
-41,201
Closed -$3.32M
AGL icon
928
Agilon Health
AGL
$1.57B
-1,847
Closed -$1.08M
AKRO
929
DELISTED
Akero Therapeutics
AKRO
-11,465
Closed -$390K
ALK icon
930
Alaska Air
ALK
$5.6B
-21,105
Closed -$826K
ALKS icon
931
Alkermes
ALKS
$8.31B
-141,467
Closed -$3.16M
ALKT icon
932
Alkami Technology
ALKT
$2.01B
-13,749
Closed -$207K
ALLO icon
933
Allogene Therapeutics
ALLO
$635M
-48,340
Closed -$522K
ALLY icon
934
Ally Financial
ALLY
$13.4B
-15,804
Closed -$440K
ALNY icon
935
Alnylam Pharmaceuticals
ALNY
$29.5B
-8,872
Closed -$1.78M
ALXO icon
936
ALX Oncology
ALXO
$260M
-23,332
Closed -$223K
AMAL icon
937
Amalgamated Financial
AMAL
$1.48B
-35,833
Closed -$808K
AMAT icon
938
Applied Materials
AMAT
$434B
-25,553
Closed -$2.09M
AME icon
939
Ametek
AME
$58.2B
-50,017
Closed -$5.67M
AMKR icon
940
Amkor Technology
AMKR
$13.9B
-79,644
Closed -$1.36M
AMPY icon
941
Amplify Energy
AMPY
$166M
-55,631
Closed -$365K
ANNX icon
942
Annexon
ANNX
$860M
-14,132
Closed -$87K
AOS icon
943
A.O. Smith
AOS
$8.25B
-81,706
Closed -$3.97M
APG icon
944
APi Group
APG
$17.2B
-71,910
Closed -$636K
APH icon
945
Amphenol
APH
$201B
-71,820
Closed -$2.4M
APPS icon
946
Digital Turbine
APPS
$1.15B
-69,253
Closed -$998K
AR icon
947
Antero Resources
AR
$11.2B
-43,995
Closed -$1.34M
ARHS icon
948
Arhaus
ARHS
$1.17B
-19,523
Closed -$138K
ARRY icon
949
Array Technologies
ARRY
$924M
-192,114
Closed -$3.19M
ARWR icon
950
Arrowhead Research
ARWR
$12.1B
-54,672
Closed -$1.81M

Similar funds

Occudo Quantitative Strategies's Q4 2022 Portfolio in Review

As of Q4 2022, Occudo Quantitative Strategies held 1,520 positions worth $859M, down 33% from $1.29B the previous quarter. Its ten largest holdings account for 4.2% of the portfolio.

Occudo Quantitative Strategies withdrew a net $442M in Q4 2022, closing 602 positions and reducing 340 holdings. Its most notable exit was Datadog, an estimated $7.11M position sold in full.

By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 22% a quarter earlier, followed by Consumer Discretionary and Industrials.

Against the trend, Occudo Quantitative Strategies opened a new position in Marvell Technology worth $3.63M.

  • Occudo Quantitative Strategies's largest Q4 2022 buy was Marvell Technology: 97,934 shares worth $3.63M.
  • Occudo Quantitative Strategies added most to Gossamer Bio in Q4 2022, an estimated $5.95M increase.
  • Occudo Quantitative Strategies's biggest Q4 2022 reduction was Align Technology, cutting an estimated $6.27M.
  • Occudo Quantitative Strategies fully exited Datadog in Q4 2022, selling an estimated $7.11M.
  • Occudo Quantitative Strategies's ten largest holdings make up 4.2% of its $859M portfolio in Q4 2022.
  • Occudo Quantitative Strategies opened 386 new positions and closed 602 in Q4 2022.
  • Occudo Quantitative Strategies's portfolio value fell 33% quarter-over-quarter to $859M.

Based on Occudo Quantitative Strategies's 13F filing for Q4 2022, filed 14 Feb 2023.